IA
ALXN

IndexIQ Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

IndexIQ Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-293,572
Closed -$53.9M – 1166
2021
Q2 		$53.9M Sell
293,572
-13,514
-4% -$2.32M 1.82% 6
2021
Q1 		$47M Buy
307,086
+304,149
+10,356% +$47M 1.66% 8
2020
Q4 		$459K Buy
2,937
+1,362
+86% +$175K 0.02% 428
2020
Q3 		$180K Buy
1,575
+948
+151% +$102K 0.01% 729
2020
Q2 		$70K Buy
+627
New +$66.6K ﹤0.01% 887
2020
Q1 		– Sell
-75
Closed -$8K – 1166
2019
Q4 		$8K Buy
+75
New +$8.02K ﹤0.01% 680
2015
Q3 		– Sell
-1
Closed – – 274
2015
Q2 		$0 Buy
+1
New +$173 ﹤0.01% 253

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

IndexIQ Advisors's ALXN Position: Q3 2021 in Review

IndexIQ Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 293,572 shares — an estimated $53.9M sold.

IndexIQ Advisors first reported a position in ALXN in Q2 2015 and held it in 7 quarters. The position peaked at $53.9M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • IndexIQ Advisors reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • IndexIQ Advisors sold 293,572 Alexion Pharmaceuticals shares in Q3 2021, an estimated $53.9M.
  • IndexIQ Advisors first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 7 quarters.
  • IndexIQ Advisors's Alexion Pharmaceuticals position peaked at $53.9M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on IndexIQ Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.